DEBIOPHARM
- Shasun Pharmaceuticals in licensing pact with Swiss-based DebiopharmShasun Pharmaceuticals would be able to use the Debiopharm technology for manufacturing synthetic Huperzine-A and commercialise it.
- US court bans Sun from selling Eloxatin: Sanofi AventisFrench drug maker Sanofi Aventis SA on Friday said a New Jersey US district court ordered Sun Pharma to stop selling its generic version of...
- Sanofi to eclipse Sun’s Eloxatin planFrance’s largest pharma company, Sanofi-Aventis, is suing India’s Sun Pharmaceuticals and Hospira’s Mayne Pharma to prevent the latter from...
- US firm files suit against Dabur PharmaUS-based Sanofi-Aventis LLC has filed a lawsuit against Dabur Pharma and its UK arm - Dabur Oncology Pte, over a USFDA filing seeking appro...
Load More- US firm files suit against Dabur Pharma